Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used

Annales de Chirurgie Plastique Esthetique

Volumn 61, Issue 1, 2016, Pages 10-15

  Risoud, M ^a   Aljudaibi, N ^a   Duquennoy Martinot, V ^a   Guerreschi, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Botulinum toxin; Dosage; Facial palsy; Kinetics

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FACE MUSCLE; FACIAL PARALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RAT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BOTULINUM TOXINS, TYPE A; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACIAL MUSCLES; FACIAL PARALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RATS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84958910298     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2015.04.002     Document Type: Article

References (18)

1. Scott A.B., Rosenbaum A., Collins C.C. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol Vis Sci 1973, 12(12):924-927.
2. Clark R.P., Berris C.E. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 1989, 84(2):353-355.
3. Armstrong M.W., Mountain R.E., Murray J.A. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci 1996, 21(1):15-20.
4. Filipo R., Spahiu I., Covelli E., Nicastri M., Bertoli G.A. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. The Laryngoscope 2012, 122(2):266-270.
5. Laskawi R., Damenz W., Roggenkämper P., Baetz A. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol 1994, S195-S199.
6. Roggenkämper P., Laskawi R., Damenz W., Schröder M., Nüssgens Z. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol Adv Ophthalmol 1994, 86(4):395-402.
7. Choi K.H., Rho S.H., Lee J.M., Jeon J.H., Park S.Y., Kim J. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthetic Surg 2013, 66(8):1058-1063.
8. Salles A.G., Toledo P.N., Ferreira M.C. Botulinum toxin injection in long-standing facial paralysis patients: improvement of facial symmetry observed up to 6 months. Aesthetic Plast Surg 2009, 33(4):582-590.
9. Dall'Angelo A., Mandrini S., Sala V., et al. Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope 2014, 10.1002/lary.24732.
10. De Maio M., Bento R.F. Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis. Plast Reconstr Surg 2007, 120(4):917-927. [discussion 928].
11. Mehta R.P., Hadlock T.A. BOtulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg 2008, 10(2):84-87.
12. Institut de veille sanitaire Bulletin épidémiologique hebdomadaire: la santé mentale en France, surveillance et enjeux 2008, 35-36.
13. Labbé D., Bénichou L., Iodice A., Giot J.-P. Signe du depressor anguli oris (DAO) dans les parésies faciales. Comment le rechercher et libérer le sourire (note technique). Ann Chir Plast Esthet 2012, 57(3):281-285.
14. Lapatki B.G., van Dijk J.P., van de Warrenburg B.P.C., Zwarts M.J. Botulinum toxin has an increased effect when targeted toward the muscle's endplate zone: a high-density surface EMG guided study. Clin Neurophysiol 2011, 122(8):1611-1616.
15. Azuma T., Nakamura K., Takahashi M., Ohyama S., Toda N., Iwasaki H., et al. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg 2012, 146(1):40-45.
16. Hauser R.A., Truong D., Hubble J., Coleman C., Beffy J.-L., Chang S., et al. AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. J Neural Transm 2013, 120(2):299-307.
17. Ruiz P.J.G., Castrillo J.C.M., Burguera J.A., Campos V., Castro A., Cancho E., et al. Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study. J Neurol 2011, 258(6):1055-1057.
18. Jankovic J., Vuong K.D., Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003, 60(7):1186-1188.